Onur E.Kabaroglu C.Inanir I.Var A.Guvenc Y.Gunay O.Gunduz K.2024-07-222024-07-22201115569535http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/17975Background: Behçet's disease (BD) is an inflammatory vasculitis. Endogenous nitric oxide (NO), produced by endothelial cells, has pleiotropic effects such as vasodilatator, antiplatelet, antiproliferative. Reactive oxygen species (ROS) are produced at sites of endothelial inflammation. ROS target polyunsaturated lipids, which results in malondialdehyde (MDA) production. Objective: The aim was to investigate the oxidative stress in BD patients by measuring MDA and total antioxidant status (TAS) levels and to establish a possible relationship with respect to NO levels regarding disease activity. Materials and methods: 55 BD patients (30 active/25 inactive) and 20 healthy volunteers were included in the study. Blood samples were drawn following an overnight fasting. TAS and MDA levels were determined spectrophotometrically. Serum nitrite (NO 2-) and nitrate (NO 3-) levels were measured to estimate NO production. Data were expressed as mean ± SD. Results: TAS levels were significantly lower in BD patients than the controls (1.19 ± 0.34 vs. 3.29 ± 0.89 mmol/L). In the active BD group, MDA levels (0.36 ± 0.19 nmol/mL) were significantly higher than both the inactive BD group (0.25 ± 0.18 nmol/mL) and controls (0.18 ± 0.41 nmol/mL). NO levels were significantly lower in the active group compared to the inactive group (18.0 ± 2.80 vs. 19.40 ± 2.70 μmol/L). MDA levels correlated negatively with NO levels in the active group. Conclusion: Decreased NO levels mediated by increased oxidative stress significantly contribute to endothelial dysfunction observed in BD. © 2011 Informa Healthcare USA, Inc.EnglishAdultAntioxidantsBehcet SyndromeCase-Control StudiesEndothelium, VascularFemaleHumansLipid PeroxidationMaleMalondialdehydeNitratesNitric OxideOxidative Stressendothelial nitric oxidemalonaldehydenitratenitric oxidenitriteunclassified drugadultarticleBehcet diseasecontrolled studydisease activityfemalehumanmajor clinical studymalemeasurementoxidative stresstotal antioxidant statusArticle10.3109/15569527.2011.554480